Sinphar Pharmaceutical Stock Forecast for 2023 - 2025 - 2030
Updated on 05/10/2024
Sinphar Pharmaceutical Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Sinphar Pharmaceutical's Price has decreased from NT$14.56 to NT$0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach NT$0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
Sinphar Pharmaceutical Revenue Forecast for 2023 - 2025 - 2030
Sinphar Pharmaceutical's Revenue has seen impressive growth In the last three years, rising from NT$2.39B to NT$2.96B – a growth of 24.05%. In the following year, 0 experts forecast that Sinphar Pharmaceutical's Revenue will decrease by 6.75%, to NT$2.76B. In 2030, professionals predict that Sinphar Pharmaceutical's Revenue will decrease by 7.48%, to NT$2.74B.
.jpg)
Sinphar Pharmaceutical Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Sinphar Pharmaceutical's Dividend per Share has grown by 400.00%, rising from NT$0.20 to NT$1.00. 0 analysts predict Sinphar Pharmaceutical's Dividend per Share will decrease by 26.67% in the next year, reaching NT$0.73. By 2030, professionals predict that Sinphar Pharmaceutical's Dividend per Share will decrease by 25.53%, to NT$0.74.
Sinphar Pharmaceutical EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Sinphar Pharmaceutical's EBITDA has seen an increase, rising from NT$112.68M to NT$518.14M. This represents a growth of 359.83%. In the following year, the 0 analysts surveyed believe that Sinphar Pharmaceutical's EBITDA will decrease by 7.74%, reaching NT$478.04M. According to professionals, by 2030, Sinphar Pharmaceutical's EBITDA will have decreased by 22.77%, falling down to NT$400.15M.
Sinphar Pharmaceutical EBIT Forecast for 2023 - 2025 - 2030
Sinphar Pharmaceutical's EBIT has seen growth In the last three years, going from NT$-122.20M to NT$288.74M – a gain of 336.28% The next year, 0 experts forecast that Sinphar Pharmaceutical's EBIT will decrease by 85.46%, reaching NT$41.99M. For the next seven years, the forecast is forEBIT to grow by 21.69%.
Sinphar Pharmaceutical EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Sinphar Pharmaceutical's EPS has decreased from NT$0.10 to NT$0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach NT$0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)